Cargando…
Nilotinib-induced Keratosis Pilaris Associated with Alopecia Areata and Eyebrow Thinning
Tyrosine kinase enzymes are an attractive target for anticancer therapies. Tyrosine kinase inhibitors (TKI) are well tolerated; somehow severe systemic side effects are rarely seen during treatment. Toxicities of skin and appendages may lead to poor compliance, psychosocial inconvenience, and drug i...
Autores principales: | Tawil, Maya Halabi, El Khoury, Rana, Tomb, Roland, Ghosn, Marwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551315/ https://www.ncbi.nlm.nih.gov/pubmed/28839396 http://dx.doi.org/10.4103/ijt.ijt_1_17 |
Ejemplares similares
-
Nilotinib-Induced Keratosis Pilaris
por: Leong, Wai Mun Sean, et al.
Publicado: (2016) -
Nilotinib-induced generalized keratosis pilaris: Report of a rare case
por: Kowe, Priyanka Arun, et al.
Publicado: (2021) -
Unilateral Linear Keratosis Pilaris on Hypopigmented Patches: An Additional Case of a New Variant of Keratosis Pilaris in an Asian Male
por: Kim, Woo-Il, et al.
Publicado: (2019) -
Dermoscopy of Keratosis Pilaris
por: Sonthalia, Sidharth, et al.
Publicado: (2019) -
Segmental alopecia areata affecting the scalp, eyebrow, and lash line: A novel presentation
por: Doyle, Claire, et al.
Publicado: (2022)